About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [124 citations: 1–100 of 121 articles]

Articles published in Hepatitis Research and Treatment have been cited 124 times. The following is a list of the 121 articles that have cited the articles published in Hepatitis Research and Treatment.

  • P. P. Basu, M. M. Aloysius, N. J. Shah, and R. S. Brown Jr, “Review article: the endocannabinoid system in liver disease, a potential therapeutic target,” Alimentary Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Christopher Koh, and T. Jake Liang, “What is the future of ribavirin therapy for hepatitis C?,” Antiviral Research, 2014. View at Publisher · View at Google Scholar
  • S. Glisic, M. Stanojevic, N. Vasiljevic, T. Bojic-Milinovic, A. Bozovic, and B. Dimitrijevic, “Response Factors To Pegylated Interferon-Alfa/Ribavirin Treatment In Chroni C Hepatitis C Patients Genotype 1B,” Archives of Biological Sciences, vol. 66, no. 1, pp. 193–201, 2014. View at Publisher · View at Google Scholar
  • Farideh Shiva, Mansour Kamali, Fariba Shirvani, Shahnaz Armin, Roxana Ghanaiei, Sedigheh Rafiei Tabatabaie, Seyed Ali Reza Fahimzad, Ahmad Reza Shamshiri, and Abdollah Karimi, “Hand Hygiene Compliance by the Health Care Staff in a Pediatric Hospital,” Archives of Pediatric Infectious Diseases, vol. 2, no. 2, 2014. View at Publisher · View at Google Scholar
  • Fatma Aykas, Dilek Unal, Samet Karahan, Emine Uslu, Mustafa Basak, and Ahmet Karaman, “Hepatitis B and C Seroprevalence in Solid Tumors - Necessity for Screening During Chemotherapy,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 3, pp. 1411–1414, 2014. View at Publisher · View at Google Scholar
  • S. A. Novosad, and K. L. Winthrop, “Beyond Tumor Necrosis Factor Inhibition: The Expanding Pipeline of Biologic Therapies for Inflammatory Diseases and Their Associated Infectious Sequelae,” Clinical Infectious Diseases, 2014. View at Publisher · View at Google Scholar
  • Minjie Lin, Shuiping Zhao, Li Shen, and Danyan Xu, “Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition,” Drug Safety, 2014. View at Publisher · View at Google Scholar
  • Ravirajsinh Jadeja, Ranjitsinh V. Devkar, and Srinivas Nammi, “Herbal Medicines for the Treatment of Nonalcoholic Steatohepatitis: Current Scenario and Future Prospects,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, pp. 1–18, 2014. View at Publisher · View at Google Scholar
  • Behzad Einollahi, Neda Raeessi, and Fereshteh Raeessi, “Can Testing for Hepatitis C Virus Core Antigen Replace the Routine Screening Assays in Patients on Hemodialysis?,” Hepatitis Monthly, vol. 14, no. 6, 2014. View at Publisher · View at Google Scholar
  • Beatriz Suay, and Maria Luisa Mateos-Lindemann, “Hepatitis E: An emerging disease,” Infection Genetics and Evolution, vol. 22, pp. 40–59, 2014. View at Publisher · View at Google Scholar
  • Jihang Chen, Hoi Shan Wong, Hoi Yan Leung, Pou Kuan Leong, Wing Man Chan, Na Chen, and Kam Ming Ko, “An ursolic acid-enriched extract of Cynomorium songaricum protects against carbon tetrachloride hepatotoxicity and gentamicin nephrotoxicity in rats possibly through a mitochondrial pathway: A comparison with ursolic acid,” Journal of Functional Foods, 2014. View at Publisher · View at Google Scholar
  • Linda Petrone, Teresa Chiacchio, Valentina Vanini, Elisa Petruccioli, Gilda Cuzzi, Cristina Di Giacomo, Luigia Pucci, Marzia Montalbano, Raffaella Lionetti, Angela Testa, Daniele Lapa, Assunta Navarra, and Ubaldo Visco-Comandini, “High urine IP-10 levels associate with chronic HCV infection,” Journal of Infection, vol. 68, no. 6, pp. 591–600, 2014. View at Publisher · View at Google Scholar
  • Al-Hazmi Ahmad Homoud, “Knowledge, attitudes and practice of primary healthcare physicians concerning the occupational risks of hepatitis B virus in Al Jouf Province, Saudi Arabia,” Journal of Infection and Public Health, 2014. View at Publisher · View at Google Scholar
  • N. S. Chandra, D. Ojha, S. Chatterjee, and D. Chattopadhyay, “Prevalence of hepatitis E virus infection in West Bengal, India: a hospital-based study,” Journal of Medical Microbiology, vol. 63, no. Pt_7, pp. 975–980, 2014. View at Publisher · View at Google Scholar
  • Danilo Agnesod, Amedeo De Nicolo, Marco Simiele, Adnan Mohamed Abdi, Lucio Boglione, and Giovanni Di Perri, “Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cell s of HCV+ patients,” Journal of Pharmaceutical and Biomedical Analysis, vol. 90, pp. 119–126, 2014. View at Publisher · View at Google Scholar
  • A. M. Egidi, T. Fenech Melillo, B. Farrugia, P. Carabot, D. Didero, G. Costanzo, and C. Mirisola, “Prevalence of latent tuberculosis, syphilis, hepatitis B and C among asylum seekers in Malta,” Journal of Public Health, vol. 36, no. 1, pp. 22–27, 2014. View at Publisher · View at Google Scholar
  • F. B. Hollinger, “Occult hepatitis B virus infection and hepatocellular carcinoma: a systemat ic review,” Journal of Viral Hepatitis, vol. 21, no. 3, pp. 153–162, 2014. View at Publisher · View at Google Scholar
  • Gloria Fioravanti, Hyma Polimera, Amanda Mayer, Fabio Dorville, and Eric Little, “Autoimmune Hepatitis in a 20-Year-Old African American Man,” Labmedicine, vol. 45, no. 2, pp. 161–171, 2014. View at Publisher · View at Google Scholar
  • S. Anitha, D. Raghunadharao, F. Waliyar, H. Sudini, M. Parveen, Ratna Rao, and P. Lava Kumar, “The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2014. View at Publisher · View at Google Scholar
  • C. Brooks Mobley, Ryan G. Toedebusch, Christopher M. Lockwood, Alexander J. Heese, Conan Zhu, Anna E. Krieger, Clayton L. Cruthirds, John C. Hofheins, Joseph M. Company, Charles E. Wiedmeyer, Dae Y. Kim, and Frank W. Booth, “Herbal adaptogens combined with protein fractions from bovine colostrum and hen egg yolk reduce liver TNF-alpha expression and protein carbonylation in Western diet feeding in rats,” Nutrition & Metabolism, vol. 11, 2014. View at Publisher · View at Google Scholar
  • Masaya Sato, Mayuko Kondo, Naoto Fujiwara, Naoya Kato, Haruhiko Yoshida, Masataka Taguri, and Kazuhiko Koike, “Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammati on, and Steatosis: A Meta-Analysis,” Plos One, vol. 9, no. 3, 2014. View at Publisher · View at Google Scholar
  • Masashi Utsumi, Akinobu Takaki, Yuzo Umeda, Kazuko Koike, Stephanie C. Napier, Nobukazu Watanabe, Hiroshi Sadamori, Susumu Shinoura, Ryuichi Yoshida, Daisuke Nobuoka, Tetsuya Yasunaka, Eiichi Nakayama, Kazuhide Yamamoto, Toshiyoshi Fujiwara, and Takahito Yagi, “Frequency of regulatory T-cell and hepatitis C viral antigen-specific immune response in recurrent hepatitis C after liver transplantation,” Transplant Immunology, 2014. View at Publisher · View at Google Scholar
  • Janaina Luz Narciso-Schiavon, and Roberto Jose de Carvalho-Filho, “Non-invasive diagnosis of liver fibrosis in chronic hepatitis C,” World Journal of Gastroenterology, vol. 20, no. 11, pp. 2854–2866, 2014. View at Publisher · View at Google Scholar
  • O. Torres, J. Matute, J. Gelineau-van Waes, J.R. Maddox, S.G. Gregory, A.E. Ashley-Koch, J.L. Showker, K.A. Voss, and R.T. Riley, “Human health implications from co-exposure to aflatoxins and fumonisins in maize-based foods in Latin America: Guatemala as a case study,” World Mycotoxin Journal, vol. 1, no. -1, pp. 1–17, 2014. View at Publisher · View at Google Scholar
  • Malihe Moradzadeh, Sirous Tayebi, Hossein Poustchi, Kourosh Sayehmiri, Parisa Shahnazari, Elnaz Naderi, Ghodratollah Montazeri, and Ashraf Mohamadkhani, “The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation,” Advances in Virology, vol. 2013, pp. 1–5, 2013. View at Publisher · View at Google Scholar
  • M. Romero-Gomez, R. Planas, J. Ampuero, R. Sola, J. Garcia-Samaniego, M. Diago, J. Crespo, J. L. Calleja, and J. Turnes, “Meta-analysis: pegylated interferon-2a achieves higher early virological re sponses than-2b in chronic hepatitis C,” Alimentary Pharmacology & Therapeutics, vol. 37, no. 11, pp. 1065–1073, 2013. View at Publisher · View at Google Scholar
  • Brian Bieber, Brenda Gillespie, Bruce M. Robinson, and Michel Jadoul, “Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients,” American Journal of Nephrology, vol. 38, no. 5, pp. 405–412, 2013. View at Publisher · View at Google Scholar
  • Ngoc Wasson, “Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepa titis C Virus Infection A Systematic Review,” Annals Of Internal Medicine, vol. 158, no. 11, pp. 807–+, 2013. View at Publisher · View at Google Scholar
  • Amedeo De Nicolo, Jessica Cusato, Alessia Ciancio, Lucio Boglione, Silvia Strona, Giuseppe Cariti, Giulia Troshina, Gian Paolo Caviglia, Antonina Smedile, Mario Rizzetto, and Giovanni Di Perri, “Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/ rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients,” Antiviral Research, vol. 100, no. 1, pp. 114–119, 2013. View at Publisher · View at Google Scholar
  • Hai Ding, Baoming Liu, Chengyu Zhao, Jingxian Yang, Chunhui Yan, Ling Yan, Hui Zhuang, and Tong Li, “Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B,” Antiviral Research, 2013. View at Publisher · View at Google Scholar
  • Montserrat Maldonado-Gonzalez, Nora A. Fierro, and Sonia Roman, “Distribution of HBV genotypes F and H in Mexico and Central America,” Antiviral Therapy, vol. 18, no. 3, pp. 475–484, 2013. View at Publisher · View at Google Scholar
  • Jobert Richie N. Nansseu, Karen K. Kengne, Shalom Tchokfe Ndoula, and Lucy A. Agyingi, “Occupational exposure to blood, hepatitis B vaccine knowledge and uptake am ong medical students in Cameroon,” Bmc Medical Education, vol. 13, 2013. View at Publisher · View at Google Scholar
  • Maria A. Jimenez-Sousa, Amanda Fernandez-Rodriguez, Maria Guzman-Fulgencio, Monica Garcia-Alvarez, and Salvador Resino, “Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C,” Bmc Medicine, vol. 11, 2013. View at Publisher · View at Google Scholar
  • In Chul An, Ashish K. Tiwari, Srujan Ameda, and Heather S. Laird-Fick, “Autoimmune Hepatitis: Diagnostic Dilemma in the Setting of Suspected Iron Overload,” Case Reports in Gastrointestinal Medicine, vol. 2013, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • Moushumi Lodh, Debkant Pradhan, and Ashok Parida, “Autoimmune Hepatitis with Anti Centromere Antibodies,” Case Reports in Immunology, vol. 2013, pp. 1–3, 2013. View at Publisher · View at Google Scholar
  • Abu Bakr Awad, Wafaa El-Akel, Wahid Doss, Tahany Awad, Amr Radwan, and Mahasen Mabrouk, “The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C,” Clinics and Research in Hepatology and Gastroenterology, vol. 37, no. 3, pp. 254–261, 2013. View at Publisher · View at Google Scholar
  • Pietro Invernizzi, Francesca Bernuzzi, Ana Lleo, Vanila Pozzoli, Monica Bignotto, Paola Zermiani, Andrea Crosignani, Pier Maria Battezzati, Massimo Zuin, Mauro Podda, and Chiara Raggi, “Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis,” Digestive and Liver Disease, 2013. View at Publisher · View at Google Scholar
  • Niraj Kumari, Rachana Kathuria, Anshu Srivastav, Narendra Krishnani, Ujjal Poddar, and Surender K. Yachha, “Significance of histopathological features in differentiating autoimmune li ver disease from nonautoimmune chronic liver disease in children,” European Journal of Gastroenterology & Hepatology, vol. 25, no. 3, pp. 333–337, 2013. View at Publisher · View at Google Scholar
  • Dong Liu, Bing Ni, Mengjun Zhang, Li Wang, and Yuzhang Wu, “Hepatitis B virus core protein interacts with CD59 to promote complement-me diated liver inflammation during chronic hepatitis B virus infection,” Febs Letters, vol. 587, no. 20, pp. 3314–3320, 2013. View at Publisher · View at Google Scholar
  • Yueqiu Luo, Caixia Jin, Zongxin Ling, Xiaozhou Mou, Qiong Zhang, and Charlie Xiang, “Association study of IL28B: rs12979860 and rs8099917 polymorphisms with SVR in patients infected with chronic HCV genotype 1 to PEG-INF/RBV therapy using systematic meta-analysis,” Gene, vol. 513, no. 2, pp. 292–296, 2013. View at Publisher · View at Google Scholar
  • Sandra Ortiz-Cuaran, David Cox, Marlin D. Friesen, Geoffroy Durand, John D. Groopman, Amelie Chabrier, Simona Ognjanovic, Florence Le Calvez-Kelm, Stephanie Villar, Thiravud Khuhaprema, and Suleeporn Sangrajrang, “Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma,” Genes Chromosomes & Cancer, vol. 52, no. 10, pp. 912–919, 2013. View at Publisher · View at Google Scholar
  • Marwa Khairy, Rabab Fouad, Mahassen Mabrouk, Wafaa El-Akel, Abu Bakr Awad, Rabab Salama, Mayada Elnegouly, and Olfat Shaker, “The Impact of Interleukin 28b Gene Polymorphism on the Virological Response to Combined Pegylated Interferon and Ribavirin Therapy in Chronic HCV Genotype 4 Infected Egyptian Patients Using Data Mining Analysis,” Hepatitis Monthly, vol. 13, no. 6, 2013. View at Publisher · View at Google Scholar
  • Saeedeh Ravi, Mohsen Nasiri Toosi, Iman Karimzadeh, and Mehdi Ahadi-Barzoki, “Adherence to Chronic Hepatitis C Treatment Regimen: First Report From a Ref erral Center in Iran,” Hepatitis Monthly, vol. 13, no. 6, 2013. View at Publisher · View at Google Scholar
  • Maryam Moini, Mazyar Ziyaeyan, Shapoor Aghaei, Mohammad Mahdi Sagheb, Seyed Alireza Taghavi, Mahsa Moeini, Marzieh Jamalidous, and Laleh Hamidpour, “Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction,” Hepatitis Monthly, vol. 13, no. 6, 2013. View at Publisher · View at Google Scholar
  • Yasuteru Kondo, Tomoaki Iwata, Takahiro Haga, Osamu Kimura, Masashi Ninomiya, Eiji Kakazu, Takayuki Kogure, Tatsuki Morosawa, Setsuya Aiba, and Tooru Shimosegawa, “Eradication of hepatitis C virus could improve immunological status and pyoderma gangrenosum-like lesions,” Hepatology Research, 2013. View at Publisher · View at Google Scholar
  • Haruki Komatsu, Ayano Inui, Tomoyuki Tsunoda, Tsuyoshi Sogo, and Tomoo Fujisawa, “Association between an IL-28B genetic polymorphism and the efficacy of the response-guided pegylated interferon therapy in children with chronic hepat ic C infection,” Hepatology Research, vol. 43, no. 4, pp. 327–338, 2013. View at Publisher · View at Google Scholar
  • Ruijuan Zhao, Hongyan Zhou, and Shao Bo Su, “A critical role for interleukin-1β in the progression of autoimmune diseases,” International Immunopharmacology, 2013. View at Publisher · View at Google Scholar
  • Michael Eisenhut, “Neopterin in Diagnosis and Monitoring of Infectious Diseases,” Journal of Biomarkers, vol. 2013, pp. 1–10, 2013. View at Publisher · View at Google Scholar
  • Yukio Osaki, “Clinical Significance of Occult Hepatitis B Infection in Progression of Liv er Disease and Carcinogenesis,” Journal Of Cancer, vol. 4, no. 6, pp. 473–480, 2013. View at Publisher · View at Google Scholar
  • B. Robert Meyer, “Autoimmune Hepatitis in Association With Ramelteon,” Journal Of Clinical Gastroenterology, vol. 47, no. 7, pp. 651–654, 2013. View at Publisher · View at Google Scholar
  • Muhammad Sadik Memon, Zain Islam Arain, Farukh Naz, Madiha Zaki, Suresh Kumar, and Asif Ali Burney, “Prevalence of Type 2 Diabetes Mellitus in Hepatitis C Virus Infected Population: A Southeast Asian Study,” Journal of Diabetes Research, vol. 2013, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • X. Chen, B. Dai, Z. Liu, J. Gao, Z. Ji, J. Guo, G. Chen, Z. Deng, and Z. Shao, “A novel B/C inter-genotype recombinant of hepatitis B virus identified in north-west China,” Journal of General Virology, vol. 95, no. Pt_1, pp. 153–155, 2013. View at Publisher · View at Google Scholar
  • Felix Stickel, Stefan Russmann, Jean-Francois Dufour, Philip P. Becker, Darius Moradpour, Michael T. Dill, David Semela, Andreas Geier, Johannes Schmitt, Christine N. Manser, Beat Muellhaupt, Michael Weisskopf, and Monika Rau, “Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum le vel, hemoglobin drop and therapeutic response in patients with HCV infectio n,” Journal Of Hepatology, vol. 58, no. 4, pp. 669–675, 2013. View at Publisher · View at Google Scholar
  • Carmelo M. Maida, Giuseppina M. E. Colomba, Paola Di Carlo, Giuseppe Montalto, Valentina Li Vecchi, Francesco Vitale, Giovanni Mazzola, and Mario Affronti, “Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy,” Journal Of Immigrant And Minority Health, vol. 15, no. 4, pp. 725–731, 2013. View at Publisher · View at Google Scholar
  • Christopher R. Bolen, Michael D. Robek, Leonid Brodsky, Vincent Schulz, Joseph K. Lim, Milton W. Taylor, and Steven H. Kleinstein, “The Blood Transcriptional Signature of Chronic Hepatitis C Virus Is Consistent with an Ongoing Interferon-Mediated Antiviral Response,” Journal of Interferon & Cytokine Research, vol. 33, no. 1, pp. 15–23, 2013. View at Publisher · View at Google Scholar
  • Jean-Pierre Allain, and Subhajit Biswas, “Specific Amino Acid Substitutions in the S Protein Prevent Its Excretion In Vitro and May Contribute to Occult Hepatitis B Virus Infection,” Journal Of Virology, vol. 87, no. 14, pp. 7882–7892, 2013. View at Publisher · View at Google Scholar
  • Noura M. Dabbouseh, and Donald M. Jensen, “Future therapies for chronic hepatitis C,” Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 5, pp. 268–276, 2013. View at Publisher · View at Google Scholar
  • Jeannette M. Beasley, Karin Aebersold, Sunil S. Jhangiani, and Judith Wylie-Rosett, “Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Di sease (NAFLD),” Nutrients, vol. 5, no. 10, pp. 4093–4114, 2013. View at Publisher · View at Google Scholar
  • Krisztina Hagymási, and Zsolt Tulassay, “Autoimmun májbetegségek átfedő (overlap) szindrómáinak áttekintése. A felismerés és a kezelés nehézségei,” Orvosi Hetilap, vol. 154, no. 24, pp. 923–929, 2013. View at Publisher · View at Google Scholar
  • Yan Zhang, Lei Shan, Yaping Hua, Dan Wang, Huawu Zeng, Runhui Liu, and Zhenlin Hu, “Baicalein Selectively Induces Apoptosis in Activated Lymphocytes and Amelio rates Concanavalin A-Induced Hepatitis in Mice,” Plos One, vol. 8, no. 7, 2013. View at Publisher · View at Google Scholar
  • Aleksander Krag, Stefan Gansweid, Peter Schiedermaier, Holger M. Strunk, Rolf Fimmers, Christian P. Strassburg, Fleming Bendtsen, Soren Moller, Tilman Sauerbruch, and Ulrich Spengler, “Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patien ts with Cirrhosis and Portal Hypertension,” Plos One, vol. 8, no. 12, 2013. View at Publisher · View at Google Scholar
  • Alessandra Dicitore, Sara Castiglioni, Giovanni Vitale, Pierosandro Tagliaferri, Alberto Abbruzzese, Monica Marra, Luca Persani, and Pasquale Sperlongano, “Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cance r Properties,” Protein And Peptide Letters, vol. 20, no. 4, pp. 412–423, 2013. View at Publisher · View at Google Scholar
  • María Teresa Pérez-Gracia, María Luísa Mateos Lindemann, and María Caridad Montalvo Villalba, “Hepatitis E: current status,” Reviews in Medical Virology, 2013. View at Publisher · View at Google Scholar
  • Rossana Pulcineli Vieira Francisco, Ana Maria Kondo Igai, Marcelo Zugaib, Roseli Mieko Yamamoto Nomura, and Roololpho Truffa Kleine, “Clinical and obstetrical management of pregnant women with autoimmune hepat itis complicated by moderate or severe thrombocytopenia,” Revista Da Associacao Medica Brasileira, vol. 59, no. 1, pp. 28–34, 2013. View at Publisher · View at Google Scholar
  • A. M. Fullerton, R. A. Roth, and P. E. Ganey, “Pretreatment With TCDD Exacerbates Liver Injury From Concanavalin A: Critical Role for NK Cells,” Toxicological Sciences, 2013. View at Publisher · View at Google Scholar
  • Rachel P.L. van Swelm, Coby M.M. Laarakkers, Marisol Kooijmans-Otero, Elke M.G.J. deJong, Rosalinde Masereeuw, and Frans G.M. Russel, “Biomarkers for methotrexate-induced liver injury: Urinary protein profiling of psoriasis patients,” Toxicology Letters, 2013. View at Publisher · View at Google Scholar
  • Pascale Buchmann, Claudia Dembek, Larissa Kuklick, Clemens Jaeger, Raindy Tedjokusumo, Miriam John von Freyend, Uta Drebber, Zbigniew Janowicz, Karl Melber, and Ulrike Protzer, “A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice,” Vaccine, vol. 31, no. 8, pp. 1197–1203, 2013. View at Publisher · View at Google Scholar
  • Wenjuan Gao, Yuhan Sun, Shiwen Chen, Jingyao Zhang, Jingjing Kang, Yongqiang Wang, Hexiang Wang, Guoliang Xia, Qinghong Liu, and Youmin Kang, “Mushroom lectin enhanced immunogenicity of HBV DNA vaccine in C57BL/6 and H BsAg-transgenic mice,” Vaccine, vol. 31, no. 18, pp. 2273–2280, 2013. View at Publisher · View at Google Scholar
  • Nathalia Mantovani, Maira Cicero, Luiz Claudio Santana, Carla Silveira, Eliane Pereira do Carmo, Paulo Roberto Ferreira Abrao, Ricardo Sobhie Diaz, and Marcos Montani Caseiro, “Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and Sao Pau lo, Brazil,” Virology Journal, vol. 10, 2013. View at Publisher · View at Google Scholar
  • Domenico Capone, and Carmine Finelli, “Exposure to ambient air particulate matter and non-alcoholic fatty liver di sease,” World Journal Of Gastroenterology, vol. 19, no. 25, pp. 3951–3956, 2013. View at Publisher · View at Google Scholar
  • Helene Jeulin, Aurelie Velay, John Murray, and Evelyne Schvoerer, “Clinical impact of hepatitis B and C virus envelope glycoproteins,” World Journal of Gastroenterology, vol. 19, no. 5, pp. 654–664, 2013. View at Publisher · View at Google Scholar
  • Rita Rezzani, Alessandra Stacchiotti, and Luigi Fabrizio Rodella, “Morphological and biochemical studies on aging and autophagy,” Ageing Research Reviews, vol. 11, no. 1, pp. 10–31, 2012. View at Publisher · View at Google Scholar
  • Peng Cheng, You Cheng, Mei X. Su, Dong Li, Guo Z. Zhao, Hui Gao, Yan Li, Jie Y. Zhu, Hua Li, and Tao Zhang, “Bicluster and Pathway Enrichment Analysis of HCV-induced Cirrhosis and Hepa tocellular Carcinoma,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 8, pp. 3741–3745, 2012. View at Publisher · View at Google Scholar
  • Hind I. Fallatah, and Hisham O. Akbar, “Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview,” Autoimmune Diseases, vol. 2012, pp. 1–17, 2012. View at Publisher · View at Google Scholar
  • Alberto R. M. Martinez, Marcelo B. Nunes, Anamarli Nucci, and Marcondes C. França, “Sensory Neuronopathy and Autoimmune Diseases,” Autoimmune Diseases, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • D. A. Gouas, S. Villar, S. Ortiz-Cuaran, P. Legros, G. Ferro, G. D. Kirk, O. A. Lesi, M. Mendy, E. Bah, M. D. Friesen, J. Groopman, I. Chemin, and P. Hainaut, “TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia,” Carcinogenesis, vol. 33, no. 6, pp. 1219–1224, 2012. View at Publisher · View at Google Scholar
  • M. Nakano, C. Saeki, H. Takahashi, S. Homma, H. Tajiri, and M. Zeniya, “Activated natural killer T cells producing interferon-gamma elicit promotin g activity to murine dendritic cell-based autoimmune hepatic inflammation,” Clinical and Experimental Immunology, vol. 170, no. 3, pp. 274–282, 2012. View at Publisher · View at Google Scholar
  • Esperance A. K. Schaefer, and Daniel S. Pratt, “Autoimmune hepatitis: current challenges in diagnosis and management in a c hronic progressive liver disease,” Current Opinion In Rheumatology, vol. 24, no. 1, pp. 84–89, 2012. View at Publisher · View at Google Scholar
  • A. Hashemi, F. Roohvand, M. H. Ghahremani, M. R. Aghasadeghi, R. Vahabpour, F. Motevali, and A. Memarnejadian, “Optimization of transfection methods for Huh-7 and Vero cells: A comparativ e study,” Cytology And Genetics, vol. 46, no. 6, pp. 347–353, 2012. View at Publisher · View at Google Scholar
  • Chih-Hung Guo, Pei-Chung Chen, Kuan-Pin Lin, Min-Yi Shih, and Wang-Sheng Ko, “Trace metal imbalance associated with oxidative stress and inflammatory sta tus in anti-hepatitis C virus antibody positive subjects,” Environmental Toxicology and Pharmacology, vol. 33, no. 2, pp. 288–296, 2012. View at Publisher · View at Google Scholar
  • Antonios Katsounas, Martin Trippler, Shyam Kottilil, Richard A. Lempicki, Guido Gerken, and Joerg F. Schlaak, “Cytokine/chemokine patterns connect host and viral characteristics with cli nics during chronic hepatitis C,” European Journal of Medical Research, vol. 17, 2012. View at Publisher · View at Google Scholar
  • Lucyna Cova, “Progress in DNA vaccination against HBV infection,” Future Virology, vol. 7, no. 2, pp. 149–160, 2012. View at Publisher · View at Google Scholar
  • Sirous Tayebi, and Ashraf Mohamadkhani, “The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection,” Hepatitis Research and Treatment, vol. 2012, pp. 1–6, 2012. View at Publisher · View at Google Scholar
  • Jennifer Y. Chen, and Raymond T. Chung, “Future Classes of Hepatitis C Virus Therapeutic Agents,” Infectious Disease Clinics of North America, vol. 26, no. 4, pp. 949–+, 2012. View at Publisher · View at Google Scholar
  • Stephanie Dominguez, Jade Ghosn, Bruno Cassard, Giovanna Melica, Isabelle Poizot-Martin, Caroline Solas, Anne-Sophie Lascaux, Magali Bouvier-Alias, Christine Katlama, Yves Levy, and Gilles Peytavin, “Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ri bavirin in patients coinfected with hepatitis C virus and HIV,” Journal Of Antimicrobial Chemotherapy, vol. 67, no. 6, pp. 1449–1452, 2012. View at Publisher · View at Google Scholar
  • Fabio Tramuto, Walter Mazzucco, Carmelo Massimo Maida, Andrea Affronti, Mario Affronti, Giuseppe Montalto, and Francesco Vitale, “Serological Pattern of Hepatitis B, C, and HIV Infections Among Immigrants in Sicily: Epidemiological Aspects and Implication on Public Health,” Journal of Community Health, vol. 37, no. 3, pp. 547–553, 2012. View at Publisher · View at Google Scholar
  • Urszula Daniluk, Celine Kerros, Rong-Hua Tao, Jillian F. Wise, Xue Ao, Zuzana Berkova, and Felipe Samaniego, “The peptide derived from the Ig-like domain of human herpesvirus 8 K1 prote in induces death in hematological cancer cells,” Journal of Experimental & Clinical Cancer Research, vol. 31, 2012. View at Publisher · View at Google Scholar
  • Fuminaka Sugauchi, Namiki Izumi, Akihiro Tamori, Masayuki Kurosaki, Naoki Hiramatsu, Yoshiyuki Suzuki, Mina Nakagawa, Minoru Sakamoto, Manabu Iwasaki, Sei Kakinuma, Kentaro Matsuura, and Naoya Sakamoto, “Data mining model using simple and readily available factors could identify patients at high risk for hepatocellular carcinoma in chronic hepatitis C,” Journal Of Hepatology, vol. 56, no. 3, pp. 602–608, 2012. View at Publisher · View at Google Scholar
  • Marina Zakalka, Georgios Germanidis, Loukas Settas, and Prodromos Hytiroglou, “Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept,” Journal Of Hepatology, vol. 56, no. 6, pp. 1420–1421, 2012. View at Publisher · View at Google Scholar
  • Antonio D'Avolio, Amedeo De Nicolo, Marco Simiele, Stefano Turini, Danilo Agnesod, Lucio Boglione, Jessica Cusato, Lorena Baietto, Giuseppe Cariti, Andrea Calcagno, Mauro Sciandra, Giovanni Di Perri, and Stefano Bonora, “Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV plus p atients,” Journal of Pharmaceutical and Biomedical Analysis, vol. 66, pp. 376–380, 2012. View at Publisher · View at Google Scholar
  • W. -X. Liu, H. -H. Zhu, W. Wu, J. -L. He, and Z. Chen, “Inhibition effect produced by dominant negative mutant fusion protein PreS2 -TLM-ScFv-HBcDN on HBV replication in vitro,” Journal of Viral Hepatitis, vol. 19, no. 4, pp. 295–300, 2012. View at Publisher · View at Google Scholar
  • Su Li, Dongsheng Zhang, Jian Sun, Zhinming Li, Liting Deng, Benyan Zou, Jing Zhan, and Wenqi Jiang, “Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclo nal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma,” Mabs, vol. 4, no. 2, pp. 256–266, 2012. View at Publisher · View at Google Scholar
  • Sarah Kutscher, Tanja Bauer, Claudia Dembek, Martin Sprinzl, and Ulrike Protzer, “Design of therapeutic vaccines: hepatitis B as an example,” Microbial Biotechnology, vol. 5, no. 2, pp. 270–282, 2012. View at Publisher · View at Google Scholar
  • Rie Osaki, Takashi Nishimura, Makoto Shioya, Takayuki Takeuchi, Yoshiaki Okumura, Tamio Nakahara, Shigeki Bamba, Shinobu Nakajo, Yoshihide Fujiyama, and Akira Andoh, “Interleukin-28B genotypes determine response to pegylated-interferon plus r ibavirin therapy in patients with hepatitis C virus infection,” Molecular Medicine Reports, vol. 5, no. 2, pp. 525–528, 2012. View at Publisher · View at Google Scholar
  • Ulrike Protzer, Mala K. Maini, and Percy A. Knolle, “Living in the liver: hepatic infections,” Nature Reviews Immunology, vol. 12, no. 3, pp. 201–213, 2012. View at Publisher · View at Google Scholar
  • Ahmed H. Mitwalli, Ashik Hayat, Jamal Alwakeel, and Durdana Hammad, “Effects of concomitant hepatitis C virus infection in patients with underly ing lupus nephritis on long-term renal outcome,” Nephrology Dialysis Transplantation, vol. 27, no. 2, pp. 627–632, 2012. View at Publisher · View at Google Scholar
  • Stephanie Villar, Sandra Ortiz-Cuaran, Behnoush Abedi-Ardekani, Doriane Gouas, Andre Nogueira da Costa, Amelie Plymoth, Thiravud Khuhaprema, Anant Kalalak, Suleeporn Sangrajrang, Marlin D. Friesen, John D. Groopman, and Pierre Hainaut, “Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thaila nd: Association with Tumors Developing in the Absence of Liver Cirrhosis,” Plos One, vol. 7, no. 6, 2012. View at Publisher · View at Google Scholar
  • Fulvio Laus, Vincenzo Villanacci, Matteo Cerquetella, Simona Corsi, Gabrio Bassotti, Giacomo Rossi, Andrea Spaterna, and Vittorio Giuliano, “Chronic hepatitis in man and in dog: a comparative update,” Revista Espanola De Enfermedades Digestivas, vol. 104, no. 4, pp. 203–209, 2012. View at Publisher · View at Google Scholar
  • Kevin L. Winthrop, “Infections and Biologic Therapy in Rheumatoid Arthritis Our Changing Unders tanding of Risk and Prevention,” Rheumatic Disease Clinics of North America, vol. 38, no. 4, pp. 727–+, 2012. View at Publisher · View at Google Scholar
  • Augustine Chen, and Chris Brown, “Distinct families of cis-acting RNA replication elements epsilon from hepat itis B viruses,” Rna Biology, vol. 9, no. 2, 2012. View at Publisher · View at Google Scholar